Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-10-27 15:06 Tx date 2020-10-27 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$480.00
+4,000 vol $0.12 each |
487,399 | |
Filed 2020-10-15 17:23 Tx date 2020-10-08 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,443
-11,100 vol $0.13 each |
133,399 | |
Filed 2020-10-15 17:08 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$12,000
+100,000 vol $0.12 each |
483,399 | |
Filed 2020-10-15 17:05 Tx date 2020-10-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$30,000
+250,000 vol $0.12 each |
383,399 | |
Filed 2020-09-14 19:13 Tx date 2020-09-10 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$9,999
+133,333 vol $0.075 each |
144,499 | |
Filed 2020-09-11 16:16 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,500 vol |
11,166 | |
Filed 2020-09-11 16:16 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-121,334 vol |
8,666 | |
Filed 2020-09-11 16:14 Tx date 2020-07-23 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-115,000 vol |
400,000 | |
Filed 2020-09-11 16:14 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
Filed 2020-09-11 16:13 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
||
Filed 2020-09-11 14:08 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
Filed 2020-09-11 14:08 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
18,833 | |
Filed 2020-09-11 14:08 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
16,333 | |
Filed 2020-09-11 14:08 Tx date 2020-08-26 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-228,667 vol |
||
Filed 2020-09-11 14:05 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
Filed 2020-09-11 13:57 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
||
Filed 2020-09-11 13:57 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$387.50
+2,500 vol $0.155 each |
247,500 | |
Filed 2020-09-11 13:53 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+2,000 vol $0.155 each |
||
Filed 2020-09-11 13:53 Tx date 2020-09-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+2,000 vol $0.155 each |
||
Filed 2020-09-11 13:52 Tx date 2020-08-20 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,200
-120,000 vol $0.01 each |
245,000 | |
Filed 2020-09-11 13:52 Tx date 2020-08-04 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,500
-150,000 vol $0.01 each |
365,000 | |
Filed 2020-07-17 15:46 Tx date 2020-07-15 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$6,750
+450,000 vol $0.015 each |
515,000 | |
Filed 2020-07-17 15:44 Tx date 2020-06-11 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,275
-85,000 vol $0.015 each |
65,000 | |
Filed 2020-06-04 23:18 Tx date 2020-06-03 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+22,000 vol $0.025 each |
150,000 | |
Filed 2020-06-04 23:17 Tx date 2020-05-27 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,850
-190,000 vol $0.015 each |
128,000 | |
Filed 2020-05-21 15:41 Tx date 2020-05-13 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-480.00
-32,000 vol $0.015 each |
318,000 | |
Filed 2020-05-01 15:26 Tx date 2020-05-01 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+40,000 vol $0.015 each |
350,000 | |
Filed 2020-04-14 17:32 Tx date 2020-04-09 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$3,750
+250,000 vol $0.015 each |
310,000 | |
Filed 2020-04-08 18:44 Tx date 2020-04-07 |
$PRMO
Primo Nutraceuticals Inc. |
DeBellefeuille, Joel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,000 |